PT UBC Medical Indonesia Tbk (IDX:LABS)

IDX:LABS Statistics

Total Valuation

IDX:LABS has a market cap or net worth of IDR 545.10 billion. The enterprise value is 553.31 billion.

Market Cap	545.10B
Enterprise Value	553.31B

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

IDX:LABS has 3.95 billion shares outstanding.

Current Share Class	3.95B
Shares Outstanding	3.95B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	n/a
Float	700.00M

Valuation Ratios

The trailing PE ratio is 66.14.

PE Ratio	66.14
Forward PE	n/a
PS Ratio	3.21
PB Ratio	3.74
P/TBV Ratio	3.88
P/FCF Ratio	64.03
P/OCF Ratio	43.68
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.74, with an EV/FCF ratio of 65.00.

EV / Earnings	67.13
EV / Sales	3.26
EV / EBITDA	19.74
EV / EBIT	43.92
EV / FCF	65.00

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.17.

Current Ratio	3.02
Quick Ratio	1.16
Debt / Equity	0.17
Debt / EBITDA	0.91
Debt / FCF	2.99
Interest Coverage	5.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.27%
Revenue Per Employee	2.74B
Profits Per Employee	132.93M
Employee Count	62
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, IDX:LABS has paid 2.34 billion in taxes.

Income Tax	2.34B
Effective Tax Rate	22.09%

Stock Price Statistics

The stock price has increased by +6.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.15%
50-Day Moving Average	135.98
200-Day Moving Average	129.67
Relative Strength Index (RSI)	56.03
Average Volume (20 Days)	1,145,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:LABS had revenue of IDR 169.80 billion and earned 8.24 billion in profits. Earnings per share was 2.09.

Revenue	169.80B
Gross Profit	62.56B
Operating Income	12.60B
Pretax Income	10.58B
Net Income	8.24B
EBITDA	27.79B
EBIT	12.60B
Earnings Per Share (EPS)	2.09

Balance Sheet

The company has 17.24 billion in cash and 25.45 billion in debt, giving a net cash position of -8.21 billion or -2.08 per share.

Cash & Cash Equivalents	17.24B
Total Debt	25.45B
Net Cash	-8.21B
Net Cash Per Share	-2.08
Equity (Book Value)	145.81B
Book Value Per Share	36.91
Working Capital	114.78B

Cash Flow

In the last 12 months, operating cash flow was 12.48 billion and capital expenditures -3.97 billion, giving a free cash flow of 8.51 billion.

Operating Cash Flow	12.48B
Capital Expenditures	-3.97B
Free Cash Flow	8.51B
FCF Per Share	2.16

Margins

Gross margin is 36.85%, with operating and profit margins of 7.42% and 4.85%.

Gross Margin	36.85%
Operating Margin	7.42%
Pretax Margin	6.23%
Profit Margin	4.85%
EBITDA Margin	16.37%
EBIT Margin	7.42%
FCF Margin	5.01%

Dividends & Yields

IDX:LABS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.51%
FCF Yield	1.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDX:LABS has an Altman Z-Score of 6.72 and a Piotroski F-Score of 4.

Altman Z-Score	6.72
Piotroski F-Score	4